Long-Term Doxycycline Therapy for Stable Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Drawbacks?
作者信息
Wang Jingcun, Gan Qiming, Zhang Haojie, Xing Qiuyun, Wu Yanjuan, Su Xiaofen, Zhang Nuofu, Wu Kang
机构信息
Sleep Medicine Center, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, National Center for Respiratory Disease, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; and.
Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
出版信息
Am J Respir Crit Care Med. 2023 Nov 15;208(10):1143-1144. doi: 10.1164/rccm.202307-1301LE.
Abstract
摘要
相似文献
1
Long-Term Doxycycline Therapy for Stable Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Drawbacks?长期使用多西环素治疗稳定期慢性阻塞性肺疾病：益处是否大于弊端？
Am J Respir Crit Care Med. 2023 Nov 15;208(10):1143-1144. doi: 10.1164/rccm.202307-1301LE.
2
Effect of doxycyline in chronic obstructive pulmonary disease - An exploratory study.多西环素对慢性阻塞性肺疾病的影响——一项探索性研究。
Pulm Pharmacol Ther. 2019 Oct;58:101831. doi: 10.1016/j.pupt.2019.101831. Epub 2019 Jul 24.
3
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed?慢性阻塞性肺疾病急性加重：需要使用抗生素吗？
Am J Respir Crit Care Med. 2010 Jan 15;181(2):102-3. doi: 10.1164/rccm.200911-1668ED.
4
Metabolomic profiling of doxycycline treatment in chronic obstructive pulmonary disease.多西环素治疗慢性阻塞性肺疾病的代谢组学分析
J Pharm Biomed Anal. 2017 Jan 5;132:103-108. doi: 10.1016/j.jpba.2016.09.034. Epub 2016 Sep 26.
5
Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease.抗生素联合全身用皮质激素治疗慢性阻塞性肺疾病急性加重。
Am J Respir Crit Care Med. 2010 Jan 15;181(2):150-7. doi: 10.1164/rccm.200906-0837OC. Epub 2009 Oct 29.
6
[No long-term effect on pathogen load].[对病原体负荷无长期影响]
MMW Fortschr Med. 2015 Nov 5;157(19):6.
7
Doxycycline Added to Prednisolone in Outpatient-Treated Acute Exacerbations of COPD: A Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial.多西环素联合泼尼松龙治疗 COPD 门诊急性加重：一项随机对照试验的成本效益分析。
Pharmacoeconomics. 2019 May;37(5):689-699. doi: 10.1007/s40273-018-0756-9.
8
Revisiting the Use of Antibiotics to Prevent COPD Exacerbation: Is Doxycycline the Answer?重新审视抗生素在预防慢性阻塞性肺疾病急性加重中的应用：强力霉素是答案吗？
Am J Respir Crit Care Med. 2023 Sep 1;208(5):509-511. doi: 10.1164/rccm.202307-1302ED.
9
Impact of long-term doxycycline on lung function & exacerbations: A real-world open, prospective pilot observation on chronic obstructive pulmonary disease.长期多西环素对肺功能和恶化的影响：一项慢性阻塞性肺疾病真实世界、开放性、前瞻性观察研究。
Indian J Med Res. 2021 Apr;153(4):465-474. doi: 10.4103/ijmr.IJMR_1254_18.
10
Influence of age on real-life effects of doxycycline for acute exacerbations among COPD outpatients: a population-based cohort study.年龄对 COPD 门诊患者急性加重期多西环素真实疗效的影响：一项基于人群的队列研究。
BMJ Open Respir Res. 2020 Feb;7(1). doi: 10.1136/bmjresp-2019-000535.
本文引用的文献
1
A Double-Blind, Randomized, Placebo-controlled Trial of Long-Term Doxycycline Therapy on Exacerbation Rate in Patients with Stable Chronic Obstructive Pulmonary Disease.一项关于长期多西环素治疗对稳定期慢性阻塞性肺疾病患者加重率影响的双盲、随机、安慰剂对照试验。
Am J Respir Crit Care Med. 2023 Sep 1;208(5):549-558. doi: 10.1164/rccm.202212-2287OC.
2
Elastin-targeted nanoparticles delivering doxycycline mitigate cytokine storm and reduce immune cell infiltration in LPS-mediated lung inflammation.靶向弹性蛋白的载多西环素纳米颗粒减轻脂多糖介导的肺部炎症中的细胞因子风暴并减少免疫细胞浸润。
PLoS One. 2023 Jun 2;18(6):e0286211. doi: 10.1371/journal.pone.0286211. eCollection 2023.
3
Data mining for detecting signals of adverse drug reaction of doxycycline using the Korea adverse event reporting system database.利用韩国不良事件报告系统数据库进行数据挖掘以检测多西环素的药物不良反应信号。
J Dermatolog Treat. 2022 Jun;33(4):2192-2197. doi: 10.1080/09546634.2021.1937480. Epub 2021 Jun 16.
4
Projecting Long-term Health and Economic Burden of COPD in the United States.预估美国慢性阻塞性肺疾病的长期健康和经济负担。
Chest. 2021 Apr;159(4):1400-1410. doi: 10.1016/j.chest.2020.09.255. Epub 2020 Oct 2.
5
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.慢性阻塞性肺疾病全球策略：诊断、管理与预防 2017 年报告。GOLD 执行摘要。
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.
6
Macrolides: a promising pharmacologic therapy for chronic obstructive pulmonary disease.大环内酯类药物：一种用于慢性阻塞性肺疾病的有前景的药物治疗方法。
Ther Adv Respir Dis. 2017 Mar;11(3):147-155. doi: 10.1177/1753465816682677. Epub 2016 Dec 28.
7
Effects of doxycycline on local and systemic inflammation in stable COPD patients, a randomized clinical trial.多西环素对稳定期慢性阻塞性肺疾病患者局部和全身炎症的影响：一项随机临床试验
Respir Med. 2016 Jan;110:46-52. doi: 10.1016/j.rmed.2015.10.009. Epub 2015 Oct 30.
8
Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial.采用培养和分子技术研究不同类别抗生素对稳定期慢性阻塞性肺疾病气道细菌的影响：一项随机对照试验
Thorax. 2015 Oct;70(10):930-8. doi: 10.1136/thoraxjnl-2015-207194. Epub 2015 Jul 15.
9
Knowledge, attitudes, and practices regarding antimalarial chemoprophylaxis in U.S. Peace Corps Volunteers--Africa, 2013.美国和平队志愿者在非洲对疟疾化学预防措施的知识、态度和实践——2013 年。
MMWR Morb Mortal Wkly Rep. 2014 Jun 13;63(23):516-7.
10
Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach.COPD 加重的病死率：荟萃分析和统计建模方法。
Eur Respir J. 2011 Mar;37(3):508-15. doi: 10.1183/09031936.00043710. Epub 2010 Jul 1.
Zotero 插件